Artesunate-pyronaridine-atovaquone-proguanil and artesunate-fosmidomycin-clindamycin compared with standard artesunate-pyronaridine for the treatment of uncomplicated malaria (MultiMal): a randomised, controlled, clinical, phase 2 trial in Gabon and Ghana.
Agobé JCD, Maïga-Ascofaré O, Adegnika AA, Pfaffendorf C, Boaheng JM, Edoa JR, Agyiri ID, Bayode Adegbite R, Bart-Plange EY, Ahenkan E, Ekoka Mbassi D, Sarpong FN, Placca E, Kwabena Kanin D, Bakari P, Loag W, Kettenbeil J, Krishna S, Lell B, Agnandji ST, Amuasi JH, Zoleko-Manego R, Mombo-Ngoma G, Kremsner PG, Wicha SG, Ramharter M, Mischlinger J.
Agobé JCD, et al. Among authors: ekoka mbassi d.
Lancet Microbe. 2026 Jan 27:101245. doi: 10.1016/j.lanmic.2025.101245. Online ahead of print.
Lancet Microbe. 2026.
PMID: 41616788
Free article.